Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (surpass-3): A randomised, open-label, parallel-group, phase 3 trial
These drugs also lower postprandial TGs and apoB48 in humans (5, 14, 15) and in mice through mechanisms requiring the GLP-1R (9)
Start your intake How Oral Semaglutide Works in Your Body Semaglutide is a glucagon-like peptide-1 receptor agonist that signals your brain's hunger control centers to reduce appetite and increase fullness signals
Cycle guidelines Cycle guidelines Approach Phase 2 reference Duration 48 weeks Review Point Every 4 weeks at each dose step Best For Matches the original NEJM trial structure Approach Phase 3 TRIUMPH reference Duration 68-72 weeks Review Point Every 4 weeks
some patients notice improvement within a few hours, while others require multiple sessions
Set expectations accordingly